
FDA is asking the public for advice on how to carry out Title VII. Among numerous other questions it is requesting comments on what information should be required at the time of entry to demonstrate a drug’s compliance, including information on homeopathic drugs for human use, articles for human or animal drug compounding, and drugs intended for research.